Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
That added production capacity for Eli Lilly's obesity pill, orforglipron, is crucial as the company races to file for its approval.
Last updated: 2025-12-10 02:37:03 ET
That added production capacity for Eli Lilly's obesity pill, orforglipron, is crucial as the company races to file for its approval.
Some analysts see ample opportunity now that the U.S. plans to allow chip sales to China again, but others worry about further geopolitical roadblocks...
Securitize hires former PayPal executive Jerome Roche as it expands regulated tokenized securities for US investors and builds on fresh approvals in E...
SS Innovations, a developer of innovative surgical robotic technologies, has submitted a 510(k) premarket notification to the US Food and Drug Adminis...
Will Netflix’s $82.7 billion deal to acquire Warner Bros. get approval from federal regulators? While Paramount was assumed to be the frontrunner to...
Gold has popped 4,000% following CFTC's approval in the 1970s, leaving Bitcoin and Ethereum with a similar scaling setup.
Paramount is considering taking an offer straight to WBD shareholders, believing its deal has a better chance of gaining regulatory approval, sources ...
SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares are trending on Friday. Check out the current price of SMX stock here. SMX surged 17...
Bitcoin-focused Twenty One Capital is set to go public on the NYSE after winning shareholder approval for its merger with Cantor Equity Partners.
The Dec. 3 approval includes an expansion of the Bundeswehr’s G95 assault rifle order, additional Joint Strike Missile purchases and new AI systems.